0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
General Anaesthetic Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-12V14293
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global General Anaesthetic Medication Market Research Report 2023
BUY CHAPTERS

General Anaesthetic Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12V14293
Report
November 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

General Anaesthetic Medication - Market Size

The global market for General Anaesthetic Medication was estimated to be worth US$ 3926 million in 2023 and is forecast to a readjusted size of US$ 4983.4 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

General Anaesthetic Medication - Market

General Anaesthetic Medication - Market

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for General Anaesthetic Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of General Anaesthetic Medication by region & country, by Type, and by Application.
The General Anaesthetic Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthetic Medication.
Market Segmentation

Scope of General Anaesthetic Medication - Market Report

Report Metric Details
Report Name General Anaesthetic Medication - Market
Forecasted market size in 2030 US$ 4983.4 million
CAGR 3.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Other
Segment by Application
  • Intravenous Anesthetics
  • Inhalational Anesthetics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of General Anaesthetic Medication manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of General Anaesthetic Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of General Anaesthetic Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the General Anaesthetic Medication - Market size in 2030?

Ans: The General Anaesthetic Medication - Market size in 2030 will be US$ 4983.4 million.

Who are the main players in the General Anaesthetic Medication - Market report?

Ans: The main players in the General Anaesthetic Medication - Market are Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang

What are the Application segmentation covered in the General Anaesthetic Medication - Market report?

Ans: The Applications covered in the General Anaesthetic Medication - Market report are Intravenous Anesthetics, Inhalational Anesthetics

What are the Type segmentation covered in the General Anaesthetic Medication - Market report?

Ans: The Types covered in the General Anaesthetic Medication - Market report are Propofol, Sevoflurane, Remifentanil, Etomidate, Isoflurane, Other

1 Market Overview
1.1 General Anaesthetic Medication Product Introduction
1.2 Global General Anaesthetic Medication Market Size Forecast
1.3 General Anaesthetic Medication Market Trends & Drivers
1.3.1 General Anaesthetic Medication Industry Trends
1.3.2 General Anaesthetic Medication Market Drivers & Opportunity
1.3.3 General Anaesthetic Medication Market Challenges
1.3.4 General Anaesthetic Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global General Anaesthetic Medication Players Revenue Ranking (2023)
2.2 Global General Anaesthetic Medication Revenue by Company (2019-2024)
2.3 Key Companies General Anaesthetic Medication Manufacturing Base Distribution and Headquarters
2.4 Key Companies General Anaesthetic Medication Product Offered
2.5 Key Companies Time to Begin Mass Production of General Anaesthetic Medication
2.6 General Anaesthetic Medication Market Competitive Analysis
2.6.1 General Anaesthetic Medication Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by General Anaesthetic Medication Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthetic Medication as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Propofol
3.1.2 Sevoflurane
3.1.3 Remifentanil
3.1.4 Etomidate
3.1.5 Isoflurane
3.1.6 Other
3.2 Global General Anaesthetic Medication Sales Value by Type
3.2.1 Global General Anaesthetic Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global General Anaesthetic Medication Sales Value, by Type (2019-2030)
3.2.3 Global General Anaesthetic Medication Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Intravenous Anesthetics
4.1.2 Inhalational Anesthetics
4.2 Global General Anaesthetic Medication Sales Value by Application
4.2.1 Global General Anaesthetic Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global General Anaesthetic Medication Sales Value, by Application (2019-2030)
4.2.3 Global General Anaesthetic Medication Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global General Anaesthetic Medication Sales Value by Region
5.1.1 Global General Anaesthetic Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global General Anaesthetic Medication Sales Value by Region (2019-2024)
5.1.3 Global General Anaesthetic Medication Sales Value by Region (2025-2030)
5.1.4 Global General Anaesthetic Medication Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America General Anaesthetic Medication Sales Value, 2019-2030
5.2.2 North America General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe General Anaesthetic Medication Sales Value, 2019-2030
5.3.2 Europe General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific General Anaesthetic Medication Sales Value, 2019-2030
5.4.2 Asia Pacific General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America General Anaesthetic Medication Sales Value, 2019-2030
5.5.2 South America General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa General Anaesthetic Medication Sales Value, 2019-2030
5.6.2 Middle East & Africa General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions General Anaesthetic Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions General Anaesthetic Medication Sales Value
6.3 United States
6.3.1 United States General Anaesthetic Medication Sales Value, 2019-2030
6.3.2 United States General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe General Anaesthetic Medication Sales Value, 2019-2030
6.4.2 Europe General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China General Anaesthetic Medication Sales Value, 2019-2030
6.5.2 China General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan General Anaesthetic Medication Sales Value, 2019-2030
6.6.2 Japan General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea General Anaesthetic Medication Sales Value, 2019-2030
6.7.2 South Korea General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia General Anaesthetic Medication Sales Value, 2019-2030
6.8.2 Southeast Asia General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India General Anaesthetic Medication Sales Value, 2019-2030
6.9.2 India General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India General Anaesthetic Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aspen Pharma
7.1.1 Aspen Pharma Profile
7.1.2 Aspen Pharma Main Business
7.1.3 Aspen Pharma General Anaesthetic Medication Products, Services and Solutions
7.1.4 Aspen Pharma General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.1.5 Aspen Pharma Recent Developments
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Profile
7.2.2 Fresenius-Kabi Main Business
7.2.3 Fresenius-Kabi General Anaesthetic Medication Products, Services and Solutions
7.2.4 Fresenius-Kabi General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.2.5 Fresenius-Kabi Recent Developments
7.3 AbbVie
7.3.1 AbbVie Profile
7.3.2 AbbVie Main Business
7.3.3 AbbVie General Anaesthetic Medication Products, Services and Solutions
7.3.4 AbbVie General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.3.5 Baxter Healthcare Recent Developments
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Profile
7.4.2 Baxter Healthcare Main Business
7.4.3 Baxter Healthcare General Anaesthetic Medication Products, Services and Solutions
7.4.4 Baxter Healthcare General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.4.5 Baxter Healthcare Recent Developments
7.5 B.Braun
7.5.1 B.Braun Profile
7.5.2 B.Braun Main Business
7.5.3 B.Braun General Anaesthetic Medication Products, Services and Solutions
7.5.4 B.Braun General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.5.5 B.Braun Recent Developments
7.6 Maruishi
7.6.1 Maruishi Profile
7.6.2 Maruishi Main Business
7.6.3 Maruishi General Anaesthetic Medication Products, Services and Solutions
7.6.4 Maruishi General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.6.5 Maruishi Recent Developments
7.7 Piramal
7.7.1 Piramal Profile
7.7.2 Piramal Main Business
7.7.3 Piramal General Anaesthetic Medication Products, Services and Solutions
7.7.4 Piramal General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.7.5 Piramal Recent Developments
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Profile
7.8.2 Hikma Pharmaceuticals Main Business
7.8.3 Hikma Pharmaceuticals General Anaesthetic Medication Products, Services and Solutions
7.8.4 Hikma Pharmaceuticals General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.8.5 Hikma Pharmaceuticals Recent Developments
7.9 Yichang Humanwell
7.9.1 Yichang Humanwell Profile
7.9.2 Yichang Humanwell Main Business
7.9.3 Yichang Humanwell General Anaesthetic Medication Products, Services and Solutions
7.9.4 Yichang Humanwell General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.9.5 Yichang Humanwell Recent Developments
7.10 Nhwa
7.10.1 Nhwa Profile
7.10.2 Nhwa Main Business
7.10.3 Nhwa General Anaesthetic Medication Products, Services and Solutions
7.10.4 Nhwa General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.10.5 Nhwa Recent Developments
7.11 Hengrui
7.11.1 Hengrui Profile
7.11.2 Hengrui Main Business
7.11.3 Hengrui General Anaesthetic Medication Products, Services and Solutions
7.11.4 Hengrui General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.11.5 Hengrui Recent Developments
7.12 Xi'an Libang
7.12.1 Xi'an Libang Profile
7.12.2 Xi'an Libang Main Business
7.12.3 Xi'an Libang General Anaesthetic Medication Products, Services and Solutions
7.12.4 Xi'an Libang General Anaesthetic Medication Revenue (US$ Million) & (2019-2024)
7.12.5 Xi'an Libang Recent Developments
8 Industry Chain Analysis
8.1 General Anaesthetic Medication Industrial Chain
8.2 General Anaesthetic Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 General Anaesthetic Medication Sales Model
8.5.2 Sales Channel
8.5.3 General Anaesthetic Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. General Anaesthetic Medication Market Trends
    Table 2. General Anaesthetic Medication Market Drivers & Opportunity
    Table 3. General Anaesthetic Medication Market Challenges
    Table 4. General Anaesthetic Medication Market Restraints
    Table 5. Global General Anaesthetic Medication Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global General Anaesthetic Medication Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies General Anaesthetic Medication Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies General Anaesthetic Medication Product Type
    Table 9. Key Companies Time to Begin Mass Production of General Anaesthetic Medication
    Table 10. Global General Anaesthetic Medication Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthetic Medication as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global General Anaesthetic Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global General Anaesthetic Medication Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global General Anaesthetic Medication Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global General Anaesthetic Medication Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global General Anaesthetic Medication Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global General Anaesthetic Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global General Anaesthetic Medication Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global General Anaesthetic Medication Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global General Anaesthetic Medication Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global General Anaesthetic Medication Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global General Anaesthetic Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global General Anaesthetic Medication Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global General Anaesthetic Medication Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global General Anaesthetic Medication Sales Value by Region (2019-2024) & (%)
    Table 27. Global General Anaesthetic Medication Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions General Anaesthetic Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions General Anaesthetic Medication Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions General Anaesthetic Medication Sales Value, (2025-2030) & (US$ Million)
    Table 31. Aspen Pharma Basic Information List
    Table 32. Aspen Pharma Description and Business Overview
    Table 33. Aspen Pharma General Anaesthetic Medication Products, Services and Solutions
    Table 34. Revenue (US$ Million) in General Anaesthetic Medication Business of Aspen Pharma (2019-2024)
    Table 35. Aspen Pharma Recent Developments
    Table 36. Fresenius-Kabi Basic Information List
    Table 37. Fresenius-Kabi Description and Business Overview
    Table 38. Fresenius-Kabi General Anaesthetic Medication Products, Services and Solutions
    Table 39. Revenue (US$ Million) in General Anaesthetic Medication Business of Fresenius-Kabi (2019-2024)
    Table 40. Fresenius-Kabi Recent Developments
    Table 41. AbbVie Basic Information List
    Table 42. AbbVie Description and Business Overview
    Table 43. AbbVie General Anaesthetic Medication Products, Services and Solutions
    Table 44. Revenue (US$ Million) in General Anaesthetic Medication Business of AbbVie (2019-2024)
    Table 45. AbbVie Recent Developments
    Table 46. Baxter Healthcare Basic Information List
    Table 47. Baxter Healthcare Description and Business Overview
    Table 48. Baxter Healthcare General Anaesthetic Medication Products, Services and Solutions
    Table 49. Revenue (US$ Million) in General Anaesthetic Medication Business of Baxter Healthcare (2019-2024)
    Table 50. Baxter Healthcare Recent Developments
    Table 51. B.Braun Basic Information List
    Table 52. B.Braun Description and Business Overview
    Table 53. B.Braun General Anaesthetic Medication Products, Services and Solutions
    Table 54. Revenue (US$ Million) in General Anaesthetic Medication Business of B.Braun (2019-2024)
    Table 55. B.Braun Recent Developments
    Table 56. Maruishi Basic Information List
    Table 57. Maruishi Description and Business Overview
    Table 58. Maruishi General Anaesthetic Medication Products, Services and Solutions
    Table 59. Revenue (US$ Million) in General Anaesthetic Medication Business of Maruishi (2019-2024)
    Table 60. Maruishi Recent Developments
    Table 61. Piramal Basic Information List
    Table 62. Piramal Description and Business Overview
    Table 63. Piramal General Anaesthetic Medication Products, Services and Solutions
    Table 64. Revenue (US$ Million) in General Anaesthetic Medication Business of Piramal (2019-2024)
    Table 65. Piramal Recent Developments
    Table 66. Hikma Pharmaceuticals Basic Information List
    Table 67. Hikma Pharmaceuticals Description and Business Overview
    Table 68. Hikma Pharmaceuticals General Anaesthetic Medication Products, Services and Solutions
    Table 69. Revenue (US$ Million) in General Anaesthetic Medication Business of Hikma Pharmaceuticals (2019-2024)
    Table 70. Hikma Pharmaceuticals Recent Developments
    Table 71. Yichang Humanwell Basic Information List
    Table 72. Yichang Humanwell Description and Business Overview
    Table 73. Yichang Humanwell General Anaesthetic Medication Products, Services and Solutions
    Table 74. Revenue (US$ Million) in General Anaesthetic Medication Business of Yichang Humanwell (2019-2024)
    Table 75. Yichang Humanwell Recent Developments
    Table 76. Nhwa Basic Information List
    Table 77. Nhwa Description and Business Overview
    Table 78. Nhwa General Anaesthetic Medication Products, Services and Solutions
    Table 79. Revenue (US$ Million) in General Anaesthetic Medication Business of Nhwa (2019-2024)
    Table 80. Nhwa Recent Developments
    Table 81. Hengrui Basic Information List
    Table 82. Hengrui Description and Business Overview
    Table 83. Hengrui General Anaesthetic Medication Products, Services and Solutions
    Table 84. Revenue (US$ Million) in General Anaesthetic Medication Business of Hengrui (2019-2024)
    Table 85. Hengrui Recent Developments
    Table 86. Xi'an Libang Basic Information List
    Table 87. Xi'an Libang Description and Business Overview
    Table 88. Xi'an Libang General Anaesthetic Medication Products, Services and Solutions
    Table 89. Revenue (US$ Million) in General Anaesthetic Medication Business of Xi'an Libang (2019-2024)
    Table 90. Xi'an Libang Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. General Anaesthetic Medication Downstream Customers
    Table 94. General Anaesthetic Medication Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. General Anaesthetic Medication Product Picture
    Figure 2. Global General Anaesthetic Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global General Anaesthetic Medication Sales Value (2019-2030) & (US$ Million)
    Figure 4. General Anaesthetic Medication Report Years Considered
    Figure 5. Global General Anaesthetic Medication Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by General Anaesthetic Medication Revenue in 2023
    Figure 7. General Anaesthetic Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Propofol Picture
    Figure 9. Sevoflurane Picture
    Figure 10. Remifentanil Picture
    Figure 11. Etomidate Picture
    Figure 12. Isoflurane Picture
    Figure 13. Other Picture
    Figure 14. Global General Anaesthetic Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global General Anaesthetic Medication Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Intravenous Anesthetics
    Figure 17. Product Picture of Inhalational Anesthetics
    Figure 18. Global General Anaesthetic Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global General Anaesthetic Medication Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America General Anaesthetic Medication Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe General Anaesthetic Medication Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific General Anaesthetic Medication Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America General Anaesthetic Medication Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa General Anaesthetic Medication Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa General Anaesthetic Medication Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions General Anaesthetic Medication Sales Value (%), (2019-2030)
    Figure 31. United States General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 37. China General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 39. China General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 49. India General Anaesthetic Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India General Anaesthetic Medication Sales Value by Type (%), 2023 VS 2030
    Figure 51. India General Anaesthetic Medication Sales Value by Application (%), 2023 VS 2030
    Figure 52. General Anaesthetic Medication Industrial Chain
    Figure 53. General Anaesthetic Medication Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS